282 related articles for article (PubMed ID: 24516357)
1. MicroRNA in cervical cancer: OncomiRs and tumor suppressor miRs in diagnosis and treatment.
Banno K; Iida M; Yanokura M; Kisu I; Iwata T; Tominaga E; Tanaka K; Aoki D
ScientificWorldJournal; 2014; 2014():178075. PubMed ID: 24516357
[TBL] [Abstract][Full Text] [Related]
2. Potential role of microRNAs in the treatment and diagnosis of cervical cancer.
Shen S; Zhang S; Liu P; Wang J; Du H
Cancer Genet; 2020 Oct; 248-249():25-30. PubMed ID: 32987255
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-411 Inhibits Cervical Cancer Progression by Directly Targeting STAT3.
Shan D; Shang Y; Hu T
Oncol Res; 2019 Feb; 27(3):349-358. PubMed ID: 29716674
[TBL] [Abstract][Full Text] [Related]
4. The Downregulation of MicroRNA-10b and its Role in Cervical Cancer.
Zou D; Zhou Q; Wang D; Guan L; Yuan L; Li S
Oncol Res; 2016; 24(2):99-108. PubMed ID: 27296950
[TBL] [Abstract][Full Text] [Related]
5. Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation.
Dong P; Xiong Y; Hanley SJB; Yue J; Watari H
J Exp Clin Cancer Res; 2017 Oct; 36(1):150. PubMed ID: 29073938
[TBL] [Abstract][Full Text] [Related]
6. A systematic study on dysregulated microRNAs in cervical cancer development.
He Y; Lin J; Ding Y; Liu G; Luo Y; Huang M; Xu C; Kim TK; Etheridge A; Lin M; Kong D; Wang K
Int J Cancer; 2016 Mar; 138(6):1312-27. PubMed ID: 26032913
[TBL] [Abstract][Full Text] [Related]
7. miR-10b Downregulated by DNA Methylation Acts as a Tumor Suppressor in HPV-Positive Cervical Cancer via Targeting Tiam1.
Yu M; Xu Y; Pan L; Feng Y; Luo K; Mu Q; Luo G
Cell Physiol Biochem; 2018; 51(4):1763-1777. PubMed ID: 30504727
[TBL] [Abstract][Full Text] [Related]
8. Expression of Micro-RNA-492 (MiR-492) in Human Cervical Cancer Cell Lines is Upregulated by Transfection with Wild-Type P53, Irradiation, and 5-Fluorouracil Treatment In Vitro.
Liu M; Wang Z; Liu Q; Zhu H; Xu N
Med Sci Monit; 2018 Oct; 24():7750-7758. PubMed ID: 30374014
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation regulated microRNAs in human cervical cancer.
Varghese VK; Shukla V; Kabekkodu SP; Pandey D; Satyamoorthy K
Mol Carcinog; 2018 Mar; 57(3):370-382. PubMed ID: 29077234
[TBL] [Abstract][Full Text] [Related]
10. Characterizing methylation regulated miRNA in carcinoma of the human uterine cervix.
Varghese VK; Shukla V; Jishnu PV; Kabekkodu SP; Pandey D; Sharan K; Satyamoorthy K
Life Sci; 2019 Sep; 232():116668. PubMed ID: 31326568
[TBL] [Abstract][Full Text] [Related]
11. Beyond HPV: oncomirs as new players in cervical cancer.
Reshmi G; Pillai MR
FEBS Lett; 2008 Dec; 582(30):4113-6. PubMed ID: 19032954
[TBL] [Abstract][Full Text] [Related]
12. Use of Mature miRNA Strand Selection in miRNAs Families in Cervical Cancer Development.
Granados-López AJ; Ruiz-Carrillo JL; Servín-González LS; Martínez-Rodríguez JL; Reyes-Estrada CA; Gutiérrez-Hernández R; López JA
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216603
[TBL] [Abstract][Full Text] [Related]
13. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
[TBL] [Abstract][Full Text] [Related]
14. miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer.
Wen SY; Lin Y; Yu YQ; Cao SJ; Zhang R; Yang XM; Li J; Zhang YL; Wang YH; Ma MZ; Sun WW; Lou XL; Wang JH; Teng YC; Zhang ZG
Oncogene; 2015 Feb; 34(6):717-25. PubMed ID: 24608427
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence.
Wilting SM; Miok V; Jaspers A; Boon D; Sørgård H; Lando M; Snoek BC; van Wieringen WN; Meijer CJ; Lyng H; Snijders PJ; Steenbergen RD
Oncotarget; 2016 Jul; 7(28):43805-43819. PubMed ID: 27270309
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 16 E6 suppresses microRNA-23b expression in human cervical cancer cells through DNA methylation of the host gene C9orf3.
Yeung CL; Tsang TY; Yau PL; Kwok TT
Oncotarget; 2017 Feb; 8(7):12158-12173. PubMed ID: 28077801
[TBL] [Abstract][Full Text] [Related]
18. A step-by-step microRNA guide to cancer development and metastasis.
Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
[TBL] [Abstract][Full Text] [Related]
19. Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124.
Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Suzuki F; Yamada T; Kudo M; Yue J; Sakuragi N
Sci Rep; 2016 Oct; 6():35480. PubMed ID: 27765948
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-374c-5p regulates the invasion and migration of cervical cancer by acting on the Foxc1/snail pathway.
Huang Y; Huang H; Li M; Zhang X; Liu Y; Wang Y
Biomed Pharmacother; 2017 Oct; 94():1038-1047. PubMed ID: 28810526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
